Market Research Reports

All Reports Home

Categories

Countries

Pharmaceuticals Reports

United Kingdom Diabetic Foot Ulcer Treatment Market By Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, and Others), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuroischemic Ulcers), By End User (Hospitals & Clinics, Ambulatory Care Centers, and Others), By Region, Competition, Forecast and Opportunities 2028

Increase in prevalence of diabetes and growing advancements in treatment of diabetic foot ulcer will drive the market in the forecast period, 2024-2028.Read More

Canada Cell and Gene Therapy Market By Type (Cell Therapy, Gene Therapy), By Indication (Oncology Diseases, Cardiovascular Diseases, Orthopedic Diseases, Neurological Diseases, and Others), By End-Users (Hospitals & Clinics, Academic & Research Institutions, and Others) and By Region, Competition, Forecast and Opportunities 2028

The growing prevalence of cancer and other diseases is expected to drive the growth of Canada cell and gene therapy market in the forecast period, 2024-2028.Read More

Ireland Generic Drugs Market By Type (Small Molecule Generics, Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, and Others), By Form (Tablet, Capsule, Injection, and Others), By Source (In House, Contract Manufacturing Organizations), Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and By Region, Competition, Forecast, and Opportunities, 2028

Rising prevalence of chronic diseases is expected to drive the growth of the Ireland generic drugs market during the forecast period.Read More

Ireland Pharmaceuticals Market By Drug Type (Generic Drugs, Branded Drugs), By Product Type (Over-The-Counter Drugs, Prescription Drugs), By Application (Cardiovascular, Oncology, Metabolic Disorder, Musculoskeletal, Anti-infective, and Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and E-Pharmacy), By Region, Competition, Forecast and Opportunities 2028

Rising incidences of chronic diseases is expected to drive the demand for the Ireland pharmaceuticals market in the forecast period, 2024-2028.Read More

Canada Anti-Hypertensive Drugs Market by Therapeutic Class (Diuretics, ACE inhibitors, ARBs, Calcium Channel Blockers, Beta Adrenergic Blockers, Renin Inhibitors, Vasodilators, Others), By Type (Primary Hypertension, Secondary Hypertension), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce Websites, Online Drug Stores) and By Region and Competition, Forecast & Opportunities 2028

The Canada anti-hypertensive drugs market is likely to be driven by the rising prevalence of hypertension during the forecast period.Read More

Argentina Pharmaceuticals Market By Drug Type (Generic, Branded drugs), By Product Type (Over-The-Counter Drugs, Prescription Drugs), By Application (Cardiovascular, Oncology, Metabolic Disorder, Musculoskeletal, Anti-infective, and Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and E-Pharmacy), and By Region, Competition, Forecast and Opportunities, 2028F

The increasing demand for healthcare is expected to drive the growth of Argentina pharmaceuticals market in the forecast period, 2024-2028.Read More

Argentina Generic Drugs Market by Type (Small Molecule, Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, and Others), By Form (Tablet, Capsule, Injection, and Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Application (Cardiovascular Disease, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, and Others), and By Region, Competition, Forecast, and Opportunities, 2028

The increasing awareness about healthcare coverage is expected to drive the growth of the Argentina generic drugs market during the forecast period.Read More

Canada Biosimilar Contract Manufacturing Market Segmented By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Technology (Mammalian, Non-mammalian), By Application (Oncology, Blood Disorders, Growth Hormonal Deficiency, Chronic & Autoimmune Disorders, Rheumatoid Arthritis, and Others), By Region, Competition, Forecast and Opportunities, 2028

The growing demand for cost effective biosimilar drugs is expected to drive the growth of Canada biosimilar contract manufacturing market in the forecast period, Read More

Turkey Generic Drugs Market - By Type (Small Molecule Generics and Bio-similars), By Mode of Drug Delivery (Oral, Parenteral, Topical, Others), By Form (Tablets, Capsules, Injections, Others), By Source (Contract Manufacturing Organizations and In-House Manufacturing), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), By Application (Cardiovascular Diseases, Diabetes, Oncology, Neurology, Anti-Inflammatory Diseases, Others) By Region, Competition, Forecast, and Opportunities, 2028

Increasing demand for robotic process automation applications, branded medicine patent expiries, and the rising prevalence of chronic diseases. are factors Read More

Canada Telemedicine Market By Component (Services & Software, Hardware), By Deployment Mode (Cloud, On-Premises), By Type (Tele-Hospitals, mHealth, and Tele-Homes), By Application (Tele-Psychiatry, General Consultations, Tele-Radiology, Tele-Pathology, and Others), By End User (Patients, Provider, and Payers), By Region, Competition, Forecast and Opportunities, 2028F

The growing demand for expanding healthcare access is expected to drive the growth of Canada telemedicine market in the forecast period, 2024-2028.Read More

Canada Generic Drugs Market By Type (Small Molecule Generics, Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, and Others), By Form (Tablet, Capsule, Injection, and Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and By Region, Competition, Forecast, and Opportunities, 2028

The increasing demand for low-cost medicines is expected to drive the growth of the Canada generic drugs market during the forecast period.Read More

Canada Regenerative Medicine Market By Type (Cell Therapies, Gene Therapies, Progenitor & Stem Cell Therapies, and Tissue Engineered Products), By Application (Musculoskeletal Disorders, Wound Care, Oncology, Ophthalmology, Neurology, Dermatology, and Others), By End User (Academic v/s Commercial), and By Region, Competition, Forecast & Opportunities, 2018-2028F

The increasing prevalence of chronic ailments is expected to drive the growth of the Canada regenerative medicine market during the forecast period.Read More

Canada Cell Therapy Manufacturing Market By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies), By Source of Cell (Autologous v/s Allogenic), By Source (In-House v/s Contract Manufacturing), By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), and By Region, Competition, Forecast & Opportunities, 2018-2028

Canada cell therapy manufacturing market is expected to grow during the forecast period due to increasing prevalence of chronic diseases.Read More

Turkey Over-The-Counter Drugs Market- By Product Type (Cough & Cold Drugs, Analgesics Drugs, Dermatology Drugs, Gastrointestinal Drugs, Vitamins, Minerals, and Supplements (VMS), Ophthalmic Drugs, Others), By Route of Drug Administration (Oral, Parenteral, Topical, Others), By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy) By Region, Competition, Forecast, and Opportunities, 2028

Increasing population, rising healthcare expenditure, and growing awareness of self-medication are factors driving the growth of the market in the forecast Read More

Malaysia Generic Drugs Market By Type (Small Molecule Generics, Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, and Others), By Drug Delivery (Oral, Topical, Parenteral, and Others), By Form (Tablet, Capsule, Injection, and Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), By Region, Competition, Forecast and Opportunities, 2028

Growing prevalence of chronic diseases and rise in geriatric population of the country will drive the generic drug market in the forecast period, 2018-2028F.Read More

Israel Generic Drugs Market, By Type (Pure Generic Drugs, Branded Generic Drugs), By Application (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), By Drug Delivery (Oral, Injectables, Dermal/Topical, and Inhalers), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies), By Region, Competition, Forecast & Opportunities, 2028

Rapid technological advancements and the rising case of chronic and infectious diseases are expected to drive the Israel generic drugs market during the forecast Read More

Canada Cancer Diagnostics Market, By Product (Consumables, Instruments), Technology (IVD Testing, Imaging, and Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, and Others), End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), By Region Competition Forecast and Opportunities, 2028

The increasing number of diagnostic centers is expected to drive the Canada cancer diagnostics market during the forecast period.Read More

Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Exosome Type (Natural v/s Hybrid), By Source (Mesenchymal Stem Cells, Blood, Body Fluids, Others), By Therapy (Immunotherapy, Chemotherapy, Gene Therapy), By Application (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Others), By End User (Hospitals & Clinics, Academics & Research Institutions, Others), By Region

Increasing molecular diagnosis and the emerging role of exosomes in the treatment of chronic diseases to drive the global exosome therapeutics market in the Read More

Egypt Personalized Nutrition Market, By Dosage Form (Tablets, Capsule, Powders, Liquids, Others), By Product Type (Dietary Supplements and Nutraceuticals, Functional Food, Functional Beverage, Digitalized DNA-based Diet, Sports Nutrigenomics, Others), By Tool Type (Genetic test kits, Food labels, Interactive apps, Portable gadgets, Wearable, Others), By Application (Standard Supplements, Disease Based, Additional Supplements, Medicinal Supplements, Sports Nutrition) By Region, Competition, Forecast & Opportunities, 2028

Increasing number of people with chronic diseases such as diabetes, hypertension, and obesity is expected to drive the growth of the Egypt personalized nutrition Read More

Canada Clinical Biomarkers Market by Product (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), By Services (Genomic Biomarker Service, Tissue Biomarker Service, Cell Service, Proteomics Service), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Immunohistochemistry, Enzyme-Linked Immunosorbent Assay, Others), By Clinical Area (Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Others), By Application (Translational Research v/s Clinical Diagnostics), By End User (Biotechnology & Pharmaceutical Companies, Diagnostic Centers, Academic & Research Institutions, Others), By Region and Competition, Forecast & Opportunities, 2018-2028

The rising prevalence of cancer is expected to drive the growth of the Canada clinical biomarkers market during the forecast period, 2024-2028.Read More

Prev    Page 26 of 30 Next